These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16098753)

  • 21. The future of motor neuron disease: the challenge is in the genes.
    Veldink JH; Van den Berg LH; Wokke JH
    J Neurol; 2004 Apr; 251(4):491-500. PubMed ID: 15083302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-pathological investigation of two patients with dementia with motor neuron disease].
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K
    Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
    Murray LM; Talbot K; Gillingwater TH
    Neuropathol Appl Neurobiol; 2010 Apr; 36(2):133-56. PubMed ID: 20202121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flaviviruses in motor neuron disease.
    Pamphlett R; Kum-Jew S; King NJ
    Muscle Nerve; 2005 Jul; 32(1):108-9. PubMed ID: 15779013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal inclusions in sporadic motor neuron disease are negative for alpha-synuclein.
    Sasaki S; Komori T; Iwata M
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):15-9. PubMed ID: 16406315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compressive lumbar myelopathy presenting as segmental motor neuron disease.
    Kleopa KA; Zamba-Papanicolaou E; Kyriakides T
    Muscle Nerve; 2003 Jul; 28(1):69-73. PubMed ID: 12811775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer and motor neuron disease: clinical study of seven cases.
    Sadot E; Carluer L; Corcia P; Delozier Y; Levy C; Viader F
    Amyotroph Lateral Scler; 2007 Oct; 8(5):288-91. PubMed ID: 17852015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finger extension weakness and downbeat nystagmus motor neurone disease (FEWDON-MND).
    Pinto WBVR; Farias IB; Badia BML; Libardi Silva LH; Yanagiura MT; Chieia MAT; Souza PVS; Oliveira ASB
    Pract Neurol; 2019 Oct; 19(5):424-426. PubMed ID: 31018990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study.
    Stephens B; Guiloff RJ; Navarrete R; Newman P; Nikhar N; Lewis P
    J Neurol Sci; 2006 May; 244(1-2):41-58. PubMed ID: 16487542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sporadic amyotrophic lateral sclerosis resembling primary lateral sclerosis: report of an autopsy case and a review of the literature.
    Tsuchiya K; Arai M; Matsuya S; Nishimura H; Ishiko T; Kondo H; Ikeda K; Matsushita M
    Neuropathology; 1999 Jan; 19(1):71-6. PubMed ID: 19519650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND.
    Josephs KA; Knopman DS; Whitwell JL; Boeve BF; Parisi JE; Petersen RC; Dickson DW
    Neurology; 2005 Aug; 65(4):645-7. PubMed ID: 16116138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotypes in ALS--clinical features and pathology].
    Sasaki S
    Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia.
    Barber SC; Wood-Allum CA; Sargsyan SA; Walsh T; Cox LE; Monk PN; Shaw PJ
    Amyotroph Lateral Scler; 2011 Jul; 12(4):257-63. PubMed ID: 21366496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The motor neuron degeneration (mnd) gene acts intrinsically in motor neurons and peripheral fibroblasts.
    Porter JC; Messer A; Peterson A
    Mol Cell Neurosci; 1997; 9(3):185-93. PubMed ID: 9245501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor neuron disease associated with multiple myeloma.
    Koc F; Paydas S; Yerdelen D; Demirkiran M
    Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of psychosocial aspects of motor neurone disease.
    McLeod JE; Clarke DM
    J Neurol Sci; 2007 Jul; 258(1-2):4-10. PubMed ID: 17445834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of motor neurone disease on language: further evidence.
    Bak TH; Hodges JR
    Brain Lang; 2004 May; 89(2):354-61. PubMed ID: 15068918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.